Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting
Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
95.89m
Last Price
$2.86
52-Week Range
$2.44 - $5.4566
04/29/2026 06:17 PM EDT
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808